Eighty-five percent of the global growth in poultry production is expected to come from emerging markets, particularly Asia. With the industry facing a trend towards both higher and more volatile feed costs, profitability will be driven by investments in optimal efficiency. Partnerships and the sharing of knowledge will be a key factor of success, as Asian poultry producers strive to feed a rapidly growing population.
Commenting on the importance of VIV Asia, Dr.Arnaud Bourgeois, Head of Ceva’s Biology business said:
“VIV Asia is a key forum which gives us the opportunity to meet face to face with our partners in the Asia Region. Having spent a significant part of my career in the region, I’m delighted to see that our heavy investments in research and development, equipment development and program formulation are appreciated by major poultry producers who see Ceva as a leading player in the fast development of the Asian poultry industry.”
Since launching its latest Newcastle vaccine - Vectormune ND at VIV Asia 2011, Ceva went further by proving its complete compatibility with its blockbuster Gumboro vaccine, Transmune IBD. Both products can now be mixed in diluent and administered in the hatchery (in-ovo or subcutaneously at day old) as a single dose giving life-long protection against Newcastle, Gumboro and Marek’s disease.
Being able to vaccinate in the hatchery against such major disease problems is a huge step forwards but of even more significance could be Ceva’s latest vector vaccine against Avian Influenza - Vectormune AI. The company has just launched the vaccine in Egypt and Bangladesh and will roll this out to other Asian countries where the problem is endemic.
“We believe that hatchery vaccination with technologically advanced vaccines is the future. Not only is there less stress on the chicks being vaccinated, improving welfare, but we can also induce long term immunity by cutting through MDA’s” said Dr Sylvain Comte, Corporate Marketing Director - Poultry “It is not simply a question of providing innovation in vaccines; we have to continue to invest in the equipment, people and programs to be able to provide the expert knowledge and vaccine solutions that will translate into improved production”
Together, beyond animal health – Ceva’s slogan will necessitate a further strengthening of the existing strong partnerships in Asia, if we are to better control diseases such as Avian Influenza, Newcastle and Gumboro, which menace poultry production and for some human health.
Commenting on the importance of VIV Asia, Dr.Arnaud Bourgeois, Head of Ceva’s Biology business said:
“VIV Asia is a key forum which gives us the opportunity to meet face to face with our partners in the Asia Region. Having spent a significant part of my career in the region, I’m delighted to see that our heavy investments in research and development, equipment development and program formulation are appreciated by major poultry producers who see Ceva as a leading player in the fast development of the Asian poultry industry.”
Since launching its latest Newcastle vaccine - Vectormune ND at VIV Asia 2011, Ceva went further by proving its complete compatibility with its blockbuster Gumboro vaccine, Transmune IBD. Both products can now be mixed in diluent and administered in the hatchery (in-ovo or subcutaneously at day old) as a single dose giving life-long protection against Newcastle, Gumboro and Marek’s disease.
Being able to vaccinate in the hatchery against such major disease problems is a huge step forwards but of even more significance could be Ceva’s latest vector vaccine against Avian Influenza - Vectormune AI. The company has just launched the vaccine in Egypt and Bangladesh and will roll this out to other Asian countries where the problem is endemic.
“We believe that hatchery vaccination with technologically advanced vaccines is the future. Not only is there less stress on the chicks being vaccinated, improving welfare, but we can also induce long term immunity by cutting through MDA’s” said Dr Sylvain Comte, Corporate Marketing Director - Poultry “It is not simply a question of providing innovation in vaccines; we have to continue to invest in the equipment, people and programs to be able to provide the expert knowledge and vaccine solutions that will translate into improved production”
Together, beyond animal health – Ceva’s slogan will necessitate a further strengthening of the existing strong partnerships in Asia, if we are to better control diseases such as Avian Influenza, Newcastle and Gumboro, which menace poultry production and for some human health.
No comments:
Post a Comment